TRA CỨU
thông tin biểu ghi
  • Bài trích
  • Ký hiệu PL/XG: 615.19
    Nhan đề: Formulation of chewing gum containing Lactobacillus brevis NB10 /
DDC 615.19
Nhan đề Formulation of chewing gum containing Lactobacillus brevis NB10 / Nhu Thi Quynh Thai, Huy Nguyen Manh, Thanh Van Tran, Anh Tuan Le
Tóm tắt Lactobacillus brevis NB10 isolated from human saliva, showed in vitro effect on inhibiting the growth and the biofilm formation of Streptococcus mutans - a major pathogen that initiates dental plaque and caries. Formulation of chewing gum containing L. brevis NB10 is the next step in using this probiotic for the prevention of dental diseases related to S. mutans. Methods: Cryoprotectants such as sorbitol, mannitol, xylitol, lactose, maltodextrin, skim milk and potassium ascorbate were selected to formulate the freeze-dried powder containing L. brevis NB10. Next, the freeze-dried powder of L. brevis NB10 was used to make chewing gum by direct compression method using HIG-04 gum base (Heath in Gum ®). Other ingredients such as xylitol, strawberry flavor powder, glycerin, aerosil, talc, and magnesium stearate were selected to formulate chewing gum with suitable chewing feel, taste, and flavor. Results: The freeze-dried powder showing the highest bacterial survival rate (75.5 ± 7.6%) consists of 6% maltodextrin, 6% skim milk, and 0.25% potassium ascorbate. The optimal formula of chewing gum tablet consists of 10% L. brevis NB10 freeze-dried powder, 10% xylitol, 2% strawberry powder, 1.5% glycerol, 1.5% magnesium stearate, 1.5% talc and 2.5% aerosil. The bacterial survival rate after tablet compression is 34.34 ± 0.55 %. The product is stable for at least 3 months at 5 ºC ± 3 ºC. Conclusion: This study was successful in formulating chewing gum containing at least 10 7 CFU/tablet of L. brevis NB10.
Từ khóa tự do Dental caries
Từ khóa tự do Freeze-drying
Từ khóa tự do Lactobacillus
Từ khóa tự do Probiotic
Từ khóa tự do Chewing gum
Tác giả(bs) CN Nguyen, Huy Manh
Tác giả(bs) CN Thai, Thi Quynh Nhu
Tác giả(bs) CN Tran, Thanh Van
Tác giả(bs) CN Le, Tuan Anh
Nguồn trích MedPharmRes 2023tr. 13-24 Số: 02 Tập: 23
000 00000nab#a2200000u##4500
00157601
0029
004C5528DFB-5CEE-4861-886F-1562BDB87B11
005202511131552
008251113s vm eng
0091 0
039|y20251113155241|ztainguyendientu
040 |aACTVN
041 |aeng
044 |avm
082 |a615.19
245 |aFormulation of chewing gum containing Lactobacillus brevis NB10 / |cNhu Thi Quynh Thai, Huy Nguyen Manh, Thanh Van Tran, Anh Tuan Le
520 |aLactobacillus brevis NB10 isolated from human saliva, showed in vitro effect on inhibiting the growth and the biofilm formation of Streptococcus mutans - a major pathogen that initiates dental plaque and caries. Formulation of chewing gum containing L. brevis NB10 is the next step in using this probiotic for the prevention of dental diseases related to S. mutans. Methods: Cryoprotectants such as sorbitol, mannitol, xylitol, lactose, maltodextrin, skim milk and potassium ascorbate were selected to formulate the freeze-dried powder containing L. brevis NB10. Next, the freeze-dried powder of L. brevis NB10 was used to make chewing gum by direct compression method using HIG-04 gum base (Heath in Gum ®). Other ingredients such as xylitol, strawberry flavor powder, glycerin, aerosil, talc, and magnesium stearate were selected to formulate chewing gum with suitable chewing feel, taste, and flavor. Results: The freeze-dried powder showing the highest bacterial survival rate (75.5 ± 7.6%) consists of 6% maltodextrin, 6% skim milk, and 0.25% potassium ascorbate. The optimal formula of chewing gum tablet consists of 10% L. brevis NB10 freeze-dried powder, 10% xylitol, 2% strawberry powder, 1.5% glycerol, 1.5% magnesium stearate, 1.5% talc and 2.5% aerosil. The bacterial survival rate after tablet compression is 34.34 ± 0.55 %. The product is stable for at least 3 months at 5 ºC ± 3 ºC. Conclusion: This study was successful in formulating chewing gum containing at least 10 7 CFU/tablet of L. brevis NB10.
653 |aDental caries
653 |aFreeze-drying
653 |aLactobacillus
653 |aProbiotic
653|aChewing gum
700 |aNguyen, Huy Manh
700 |aThai, Thi Quynh Nhu
700 |aTran, Thanh Van
700|aLe, Tuan Anh
7730 |tMedPharmRes |d2023|gtr. 13-24|x2615-9139|v23|i02
890|a0|b0|c1|d1
Không tìm thấy biểu ghi nào